Transcriptional adaptation of the heart to mechanical unloading

American Journal of Cardiology

Volumn 83, Issue 12 A, 1999, Pages 58-63

  Depre, Christophe ^a   Davies, Peter J A ^a   Taegtmeyer, Heinrich ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; ANIMAL EXPERIMENT; CONFERENCE PAPER; GENE EXPRESSION; HEART FAILURE; HEART FUNCTION; HEART VENTRICLE HYPERTROPHY; HEART WORK; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRANSCRIPTION REGULATION;

EID: 0033577967     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00260-X     Document Type: Conference Paper

References (58)

1. Cohn J., Bristow M.R., Chien K.R., Colucci W.S., Frazier O.H., Leinwand L.A., Lorell B.H., Moss A.J., Sonnenblick E.H., Walsh R.A., Mockrin S.C., Reinlib L. Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on heart failure research. Circulation. 95:1997;766-770.
2. Muller J., Wallukat G., Weng Y.G., Dandel M., Spiegelsberger S., Semrau S., Brandes K., Theodoridis V., Loebe M., Meyer R., Hetzer R. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation. 96:1997;542-549.
3. Dipla K., Mattiello J., Jeevanandam V., Houser S., Margulies K. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation. 97:1998;2316-2322.
4. Zafeiridis A., Jeevanandam V., Houser S., Margulies K. Regression of cellular hypertrophy after left ventricular assist device support. Circulation. 98:1998;656-662.
5. Scheuer J. Metabolic factors in myocardial failure. Circulation. 87:1993;VII-54-VII-57.
6. Sack M.N., Rader T.A., Park S., Bastin J., McCune S.A., Kelly D.P. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation. 94:1996;2837-2842.
7. Sack M.N., Disch D.L., Rockman H.A., Kelly D.P. A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophy growth program. Proc Natl Acad Sci USA. 94:1997;6438-6443.
8. Depre C., Shipley G., Davies P., Frazier O., Taegtmeyer H. Glucose transporter isoform expression in the failing human heart. Circulation. 98:1998;I-627. (Abstr).
9. Gradinak S., Coleman G.M., Taegtmeyer H., Sweeney M.S., Frazier O.H. Improved cardiac function with glucose-insulin-potassium after coronary bypass surgery. Ann Thorac Surg. 48:1989;484-489.
10. Lazar H.L. Enhanced preservation of acutely ischemic myocardium using glucose-insulin-potassium solutions. J Cardiol Surg. 9:(suppl):1994;474-478.
11. Taegtmeyer H., Goodwin G.W., Doenst T., Frazier O.H. Substrate metabolism as a determinant for postischemic functional recovery of the heart. Am J Cardiol. 80:1997;3A-10A.
12. Depre C., Vanoverschelde J., Taegtmeyer H. Glucose for the heart. Circulation. 99:1999;578-588.
13. Nakao K., Minobe W., Roden R., Bristow M.R., Leinwand L.A. Myosin heavy chain gene expression in human heart failure. J Clin Invest. 100:1997;2362-2370.
14. Arai M., Matsui H., Periasamy M. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res. 74:1994;555-564.
15. Murphy A. Contractile protein phenotypic variation during development. Cardiovasc Res. 31:1996;E25-E33.
16. Nadal-Ginard B., Mahdavi V. Molecular basis of cardiac performance plasticity of the myocardium generated through protein isoform switches . J Clin Invest. 84:1989;1693-1700.
17. Schneider M., Roberts R., Parker T. Modulation of cardiac genes by mechanical stress. The oncogene signalling hypothesis. Mol Biol Med. 8:1991;167-183.
18. Parker T., Schneider M. Growth factors, proto-oncogenes, and plasticity of the cardiac phenotype. Annu Rev Physiol. 53:1991;179-200.
19. Lompre A., Schwartz K., d'Albis A., Lacombe G., Van Thiem N., Swynghedauw B. Myosin isoenzyme redistribution in chronic heart overload. Nature. 282:1979;105-107.
20. Mercadier J., Lompre A., Wisnewsky C., Samuel J., Bercovici J., Swynghedauw B., Schwartz K. Myosin isoenzymic changes in several models of rat cardiac hypertrophy. Circ Res. 49:1981;525-532.
21. Izumo S., Lompre A.M., Matsuoka R., Koren G., Schwartz K., Nadal-Ginard B., Mahdavi V. Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. J Clin Invest. 79:1987;970-977.
22. Izumo S., Nadal-Ginard B., Mahdavi V. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci USA. 85:1988;339-343.
23. Schwartz K., de la Bastie D., Bouveret P., Oliviero P., Alonso S., Buckingham M. α-Skeletal muscle actin mRNA's accumulate in hypertrophied adult rat hearts. Circ Res. 59:1986;551-555.
24. Schwartz K., Boheler K.R., de la Bastie D., Lompre A.M., Mercadier J.J. Switches in cardiac muscle gene expression as a result of pressure and volume overload. Am J Physiol. 262:1992;R364-R369.
25. Klein I., Ojamaa K., Samarel A., Welikson R., Hong C. Hemodynamic regulation of myosin heavy chain expression. J Clin Invest. 89:1992;68-73.
26. Klein I., Hong C. Effects of thyroid hormone on cardiac size and myosin content of the heterotopically transplanted rat heart. J Clin Invest. 77:1986;1694-1698.
27. Charlemagne D., Orlowski J., Oliviero P., Rannou F., Sainte Beuve C., Swynghedauw B., Lane L.K. Alteration of Na,K-ATPase subunit mRNA and protein levels in hypertrophied rat heart. J Biol Chem. 269:1994;1541-1547.
28. Lucchesi P., Sweadner K. Postnatal changes in Na,K-ATPase isoform expression in rat cardiac ventricle. J Biol Chem. 266:1991;9327-9331.
29. 2+-dependent adenosine triphosphatase from rat cardiac sarcoplasmic reticulum. J Clin Invest. 83:1989;1102-1108.
30. 2+-ATPase and phospholamban mRNA expression in response to pressure overload and thyroid hormone. Proc Natl Acad Sci USA. 86:1989;2966-2970.
31. Orlowski J., Lingrel J. Tissue-specific and developmental regulation of rat Na,K-ATPase catalytic α isoform and subunit mRNAs. J Biol Chem. 263:1988;10436-10442.
32. Depre C., Shipley G., Chen W., Han Q., Doenst T., Moore M., Stepkowski S., Davies P., Taegtmeyer H. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nature Med. 4:1998;1269-1275.
33. Chien K.R., Zhu H., Knowlton K.U., Miller-Hance W., Van Bilsen M., O'Brien T.X., Evans S.M. Transcriptional regulation during cardiac growth and development. Annu Rev Physiol. 55:1993;77-95.
34. Komuro I., Yazaki Y. Control of cardiac gene expression by mechanical stress. Annu Rev Physiol. 55:1993;55-75.
35. Sadoshima S., Izumo S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol. 59:1997;551-571.
36. Crozatier B. Stretch-induced modifications of myocardial performance from ventricular function to cellular and molecular mechanisms . Cardiovasc Res. 32:1996;25-37.
37. Sadoshima J., Izumo S. Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes potential involvement of an autocrine/paracrine mechanism . EMBO J. 12:1993;1681-1692.
38. Sugden P., Clerk A. "Stress-responsive" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ Res. 83:1998;345-352.
39. 1-adrenergic reactivation of the fetal gene program in cardiac myocytes. Circ Res. 83:1998;43-49.
40. Hasegawa K., Lee S., Jobe S., Markham B., Kitsis R. cis-Acting sequences that mediate induction of β-myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction. Circulation. 96:1997;3943-3953.
41. Doud S., Pan L., Carleton S., Marmorstein S., Siddiqui M. Adaptational response in transcription factors during development of myocardial hypertrophy. J Mol Cell Cardiol. 27:1995;2359-2372.
42. Schaub M., Hefti M., Zuellig R., Morano I. Modulation of contractility in human cardiac hypertrophy by myosin essential light chain isoforms. Cardiovasc Res. 37:1998;381-404.
43. Ono K., Lindsey E.S. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg. 57:1969;225-229.
44. McNulty P.H., Liu W.X., Luba M.C., Valenti J.A., Letsou G.V., Baldwin J.C. Effect of nonworking heterotopic transplantation on rat heart glycogen metabolism. Am J Physiol. 268:1995;E48-E54.
45. Hornby L., Hamilton N., Marshall D., Salerno T.A., Laughlin M.H., Ianuzzo C.D. Role of cardiac work in regulating myocardial biochemical characteristics. Am J Physiol. 258:1990;H1482-H1490.
46. ++ transport in atrophic heart transplants in rat. Am J Physiol. 251:1986;H941-H948.
47. Robbins J. Regulation of cardiac gene expression during development. Cardiovasc Res. 31:1996;E2-E16.
48. Sugden P., Bogoyevitch M. Intracellular signalling through protein kinases in the heart. Cardiovasc Res. 30:1995;478-492.
49. Sussman M., Lim H., Gude N., Taigen T., Olson E., Robbins J., Colbert M., Gualberto A., Wieczorek D., Molkentin J. Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science. 281:1998;1690-1693.
50. Zhao M., New L., Kravchenko V., Kato Y., Gram H., Di Padova F., Olson E., Ulevitch R., Han J. Regulation of the MEF2 family of transcription factors by p38. Mol Cell Biol. 19:1999;21-30.
51. Peng S., Chen C., Xu N., Shyu A. RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J. 17:1998;3461-3470.
52. Xu N., Chen C., Shyu A. Modulation of the fate of cytoplasmic mRNA by AU-rich elements. Mol Cell Biol. 17:1997;4611-4621.
53. Welsh G., Proud C. Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B. Biochem J. 294:1993;625-629.
54. Pause A., Belsham G., Gingras A., Donze O., Lin T., Lawrence J., Sonenberg N. Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′-cap function. Nature. 371:1994;762-767.
55. Lin T., Kong X., Haystead T., Pause A., Belsham G., Sonenberg N., Lawrence J. PHAS-I as a link between mitogen-activated protein kinase and translation initiation. Science. 266:1994;653-656.
56. Giancotti F. Integrin signaling specificity and control of cell survival and cell cycle progression . Curr Opin Cell Biol. 9:1997;691-700.
57. Olivieri N., Rees D., Ginder G., Thei S., Brittenham G., Waye J., Weatherall D. Treatment of thalassaemia major with phenylbutyrate and hydroxyurea. Lancet. 350:1997;491-492.
58. Deconinck N., Tinsley J., De Backer F., Fisher R., Kahn D., Phelps S., Davies K., Gillis J. Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice. Nature Med. 3:1997;1216-1221.